Connection device for generating sterile solution in a dropper bottle from a pharmaceutical vial containing powdered or lyophilized medications
Patent Information
- Application Number
- ES2025031213
- Authority / Receiving Office
- ES · ES
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-12-19
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2045-12-19
AI Technical Summary
Current methods for reconstituting chemically unstable medications, particularly for ocular administration, require aseptic mixing and transfer processes that are complex, non-sterile, and labor-intensive, limiting their use to healthcare settings and necessitating immediate preparation, which is not feasible for home use.
A one-piece connection device that allows aseptic mixing and transfer of powdered or lyophilized medications from a pharmaceutical vial to an eye dropper bottle, ensuring sterility and simplifying the process for domestic use, using a snap-fit mechanism and internal needle for mixing and transferring the medication.
Enables aseptic reconstitution and storage of unstable medications in a dropper bottle, ensuring sterility and reducing healthcare personnel workload, allowing immediate access and use of eye drops without hospital visits.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
Connection device for generating sterile solution in a dropper bottle from a pharmaceutical vial containing powdered or lyophilized medications TECHNICAL SECTOR This invention falls within the framework of the pharmaceutical industry, allowing the marketing of eye drops with active ingredients that are not stable in solution, as a simple aseptic reconstitution is possible by users at home. The invention also falls within the scope of pharmacy services, allowing the production of a larger quantity of unstable eye drops, which after lyophilization can be preserved for a long time, and distributed in the hospital, so that when needed, the healthcare staff reconstitute them and administer them to the patient, without the delays involved in having to prepare them one by one after request for each of the patients when the need arises. Advantageously, the present invention is suitable for both domestic and clinical use. Being a single-piece device, it can be easily used by healthcare personnel, users, or patients, ensuring the sterility of the medication and resulting in cost savings for healthcare personnel and manufacturing. BACKGROUND OF THE INVENTION Currently, many medications are composed of chemically unstable substances in an aqueous environment. These medications cannot be manufactured by the pharmaceutical industry in solution for administration to patients without prior manipulation. In these cases, some transfer systems have been developed that allow or incorporate devices so that, when these medications need to be used by the user, the components of the medications (which can only be in the form of soluble powder, or lyophilized due to their chemical instability in solution) can be mixed with the liquid in which they will be dissolved in order to be administered. In these cases, the rapid degradation time only starts counting from the moment of the powder-liquid mixture until the container is completely consumed, a time that is generally short. There are commercially available intravenous devices that attach a vial to a liquid-filled administration bag. Squeezing the bag forces some of the liquid into the vial containing the powder, dissolving it. Then, by inverting the system and applying successive compressions, the dissolved medication is drawn into the bag for administration. This transfer is considered aseptic. In other cases, for medications that must be administered orally, those that are not stable in solution are administered as a soluble powder. Users are instructed to open the bottles, fill them with water to a mark on the bottle, close them, and shake the contents until the powder dissolves. Once dissolved, the degradation time begins. This is considered non-aseptic reconstitution, as aseptic technique is not required for medications administered orally. When it comes to eye drops, due to their short shelf life, they must be prepared immediately before administration to the patient. This process is usually carried out in hospital pharmacy departments, as reconstitution requires dilution and fractionation of the contents of pharmaceutical vials using syringes and needles under aseptic conditions. These medications typically require the mixture of two or more substances, one or a mixture of substances in a solid state and the other in a liquid state. The solid component results from a filling process when the products are highly soluble, or from lyophilization if they are not. Freeze-drying is a technique in which a completely frozen sample is subjected to a vacuum process, reducing the surrounding pressure to allow the frozen water in the substance to pass directly from the solid phase to the gaseous phase. This removes the water from the sample without altering any of the product's characteristics, allowing for its preservation for an extended period. The liquid substance is stored in a plastic bottle or similar container. Following traditional methods, the liquid from the ampoules accompanying the vials is drawn using a syringe, added to the vial containing the lyophilized substance, and, once mixed, the syringe is used again to draw the liquid and transfer the mixture to a dosing bottle with a dropper nozzle. This dropper bottle, containing the mixed medication, is what is finally dispensed to the end user. In this regard, it is worth mentioning Utility Model number ES0292070, which consists of an anti-rotation device for two-component vial closure capsules. While it allows for the mixing of solid and liquid components and enables oral administration of the medication, it does not provide for the sterility of the solid component, nor does it allow for its aseptic transfer to an eye dropper bottle, thus limiting ocular administration of the medication, a legal requirement for all eye drops. On the other hand, Spanish patent number ES2446972 describes a fluid transfer device with a sealing mechanism that allows for a concentric assembly to be press-fitted onto the rim of the vial. A tubular cannula pierces the vial's membrane, facilitating access to the liquid within the container. However, the other end of the device does not allow for the attachment of a drip infusion set for the patient, limiting its use exclusively to healthcare settings. While other systems similar to patent ES2446972 exist that utilize a syringe with or without a needle, none offer the option of adapting a standard drip bottle. Therefore, it should be noted that currently, it is the responsibility of healthcare personnel to mix the medication by introducing the liquid component with a needle capable of piercing the membrane of the pharmaceutical vial containing the solid substance. Likewise, once mixed, the same personnel must draw it up and transfer it with the same syringe to a container for the patient's use. This procedure ensures the medication remains sterile and allows the patient to use it directly by receiving the mixture in a standard dropper bottle. The entire process must be repeated each time a container is used up, until the patient's treatment is complete. These drawbacks can be overcome by means of the connection device of the present invention. In this regard, the applicant identifies the need to offer a one-piece device for connecting a pharmaceutical vial, containing soluble powder or lyophilized powder, to an eye dropper bottle containing dissolving liquid. This allows the patient to reconstitute the mixture aseptically and without the need for other elements (syringes, needles, etc.), thus obtaining a medication ready for use and storage in a home setting. Additionally, it optimizes and reduces the workload of healthcare personnel and provides urgent and immediate access to ocular medications, without the delays associated with their preparation in the pharmacy. EXPLANATION OF THE INVENTION The main objective of the invention is to offer a one-piece connecting body between a dropper bottle and a pharmaceutical vial that allows the appropriate properties of the substances or components of the medicine to be maintained throughout the process, until the final dosage by the patient or user assisting the patient, and that, in addition, the medicine remains sterile throughout the useful life of the container in the domestic environment. To this end, the present invention is adapted to standard pharmaceutical vials (with a metal cap and seal) and standard commercial eye dropper bottles. It allows the sealed vial cap to be pierced by pressure, and the solid components of the vial and the liquid components of the dropper bottle to be aseptically mixed and then transferred to the eye dropper bottle, which is the one the user ultimately uses to administer the drops into the eye. This device will allow the pharmaceutical industry to market drugs that are not stable in solution for ocular administration in the form of eye drops, as they can be reconstituted aseptically by the end user, whenever required, without the need to use any other additional material. In this sense, the present invention advocates a connection device between a pharmaceutical vial with medicines in powder or lyophilized form and a dropper bottle, which contains a liquid, for the generation of a sterile solution that is stored in the eye dropper bottle, which is formed by a one-piece body with a first sector, at whose end the dropper bottle is fitted, and a second sector, at whose end opposite the end of the first sector the pharmaceutical vial is connected. More specifically, the dropper bottle attaches to the connecting device via an internal thread located at the end of the first section, and the pharmaceutical vial is connected by pressure to the opposite end, located in the second section, through snap-fit flaps. To ensure a secure connection between the pharmaceutical vial and the connecting device, the snap-fit flaps are defined by grooves and contain locking tabs. To allow the liquid to pass from the dropper bottle to the pharmaceutical vial via the connecting device of the invention, and subsequently for the medication to pass from the pharmaceutical vial to the dropper bottle, a needle is arranged inside the second section. This needle connects the first and second sections, so that once the user attaches the dropper bottle and pierces the membrane of the pharmaceutical vial with the needle, the medication is transferred through the needle. The needle consists of a sharp distal end and at least one internal channel, which has at least one laterally positioned orifice. Thus, the liquid from the dropper bottle is transferred through the needle's internal channel and flows through the needle's orifice into the pharmaceutical vial. Subsequently, the medication is transferred from the pharmaceutical vial to the eye dropper bottle for the user, eliminating the need for a hospital visit. In other words, the device of the invention enables the transfer of medication between the dropper bottle and the pharmaceutical vial. The following details the phases in which the connection device of the invention participates, ensuring safe and sterile mixing and application throughout the process. The patient is supplied with: the connection device (packaged and sterile), the pharmaceutical vial containing the drug in the form of a soluble powder or lyophilized powder (if it was not previously soluble), sterile and hermetically sealed, and the dropper bottle containing the liquid substance (usually water for injection or water containing a preservative), hermetically sealed and sterile. The user removes the seal from the pharmaceutical vial and slightly opens the connector package at the end containing the needle or punch, without touching it, and presses it against the pharmaceutical vial, until the needle passes through the stopper or membrane of the vial and the adjustment flaps and internal locking tabs of the connector lock the connector to prevent it from separating from the pharmaceutical vial during the drug preparation process, maintaining the sterility of the drug. The patient opens the cap of the eye dropper bottle and screws it onto the end of the connection device of the invention that has the internal threading, and holding the dropper bottle by its body, taking care not to come into contact with the internal threading of the connection device or the thread of the dropper bottle. The end of the connecting device has an internal thread into which the dropper bottle, containing the liquid mixture, is attached. This fitting allows the liquid to be transferred from the dropper bottle to the pharmaceutical vial by pumping the dropper bottle. This process must be carried out with the pharmaceutical vial at the bottom and the dropper bottle at the top of the connecting device. The internal channel of the needle allows the exchange of liquid and air between the two containers to facilitate mixing. Once the liquid is transferred from the dropper bottle to the pharmaceutical vial, the assembled unit (pharmaceutical vial, connection device and dropper bottle) is gently shaken until the powder contained in the pharmaceutical vial is completely dissolved in the liquid, obtaining the medicine. Once the medication is mixed, the connecting device with the pharmaceutical vial and dropper bottle is rotated 180 degrees, placing the dropper bottle at the bottom and the vial at the top. The dropper bottle is pumped several times, forcing air and pressure into the vial through the internal needle port and collecting the dissolved medication when the pump is released. This process is repeated several times until all the liquid from the pharmaceutical vial has been transferred to the eye dropper bottle. The internal needle port port facilitates the transfer again, preventing a vacuum from forming. Once the medication has been transferred to the dropper bottle, unscrew it from the connector and replace the original cap. The eye drops are now ready for use. The stopper on the eye dropper bottle allows the medication to be preserved when not in use. DESCRIPTION OF THE DRAWINGS To complement the description that follows and to aid in a better understanding of the characteristics of the present invention, according to a preferred embodiment thereof, a set of drawings is included as an integral part of said description, in which, for illustrative and non-limiting purposes, the following has been represented: Figure 1: Isometric view of the connection device showing that the invention consists of a single piece. Figure 2: Isometric view of the dropper bottle without the cap that is currently marketed in different dimensions. Figure 3: Isometric view of the pharmaceutical vial, which is marketed in different dimensions. Figure 4: General isometric view of the assembled set (pharmaceutical vial, connection device and dropper bottle). Figure 5A: Profile view of the assembly shown in Figure 4. Figure 5B: Longitudinal section view (AA) shown in Figure 5A, where you can see how the different elements that make up the assembly fit together internally: connection device, dropper bottle and pharmaceutical vial. Figure 6: General isometric view from below of the connection device. Figure 7: Front view of the connection device elevation. Figure 8: A profile and sectional view of the device in Figure 7 according to an imaginary vertical diametral cutting plane. Figure 9: Shows another bottom perspective view of the connecting device of the invention PREFERRED EMBODIMENT OF THE INVENTION In view of the figures described, it can be observed how in said figures the connection device (1) of the invention is represented and the commercial devices that correspond to a commercial dropper bottle (2) and a commercial pharmaceutical vial (3). A preferred embodiment of the connection device (1) covered by this document is described below, without limitation as to its formal constitution or minor variations that are of no importance in terms of modifying its main function. As can be seen in Figures 1 and 7, the connection device (1) for generating a sterile solution in a dropper bottle from a pharmaceutical vial (3) containing powdered or lyophilized medication consists of a single piece with two distinct sections (Figure 8): a first section (12) with one end (4) containing an internal thread (10) for fitting the dropper bottle (2), and a second section (13) with adjustment flaps (5) located at the opposite end (6) from the end (4) of the first section (12), with different elements that allow for mixing a solid substance contained in the pharmaceutical vial (3) (Figure 3) and a liquid substance contained in the dropper bottle (2) (Figure 2). Figures 4 and 5 show the assembly of the connection device with the two commercial containers, the dropper bottle (2) and the pharmaceutical vial (3). The upper part of Figures 1 and 8 shows the end (4) of the device of the invention containing the internal thread (10) for assembling the dropper bottle (2), a detail that can be seen in the longitudinal section (AA) shown in Figure 5B. At the opposite end (6) (Figures 7 to 9), the adjustment flaps (5) are shown, delimited by grooves (7) that provide flexibility to the adjustment flaps (5). To ensure a tight seal, the adjustment flaps (5) have internal locking tabs (8) to lock the connection device (1) to the pharmaceutical vial (3) by pressure. As for the pharmaceutical vial (3), shown in Figure 3, its top is sealed by a silicone membrane and a metal piece, which keeps the previously lyophilized solid substance inside sterile and the vial hermetically sealed. The second sector (13), as can be seen in figure 8, has inside a needle (9), which connects the first sector (12) with the second sector (13) and which pierces the membrane of the pharmaceutical vial (3). In the preferred embodiment of the invention, the needle is formed by a sharpened distal end and by two internal channels (14), each internal channel (14) having a laterally arranged orifice (11). Thus, the needle (9) contains holes (11) (figure 9) which, once the membrane of the pharmaceutical vial (3) is pierced and the pharmaceutical vial (3) is attached to the connection device (1), allow the transfer of the liquid substance from the dropper bottle (2) to the pharmaceutical vial (3) and subsequently the medicine from the pharmaceutical vial to the dropper bottle (2) and the exit of air through the holes (11) of the internal channels (14) (figure 8) present inside the needle (9), so that the user has the sterilized dispenser with its corresponding dose for domestic use.
Claims
1.- Connection device (1) for generating sterile solution in a dropper bottle (2) from a pharmaceutical vial (3) containing powdered or lyophilized medicines, characterized in that it is constituted from a one-piece body in which a first sector (12) is defined with an internal thread (10) at its end (4) to fit the dropper bottle (2), as well as a second sector (13) defined by adjustment flaps (5) arranged at the opposite end (6) to the first sector (12), such that the adjustment flaps (5) are delimited by grooves (7) giving a flexible character to the adjustment flaps (5), the adjustment flaps (5) including internally locking tabs (8) for pressure connection to the pharmaceutical vial (3), such that in the second sector (13) there is an internally arranged needle (9) that connects the first sector (12) with the second sector (13), where The needle (9) is formed by a sharp distal end and with,at least one internal channel, the channel having at least one orifice; wherein the needle (9) defines a means of piercing the membrane of the pharmaceutical vial (3) for the transfer of medicines between the dropper bottle (2) and the pharmaceutical vial (3). 2.- Connection device (1), according to claim 1, characterized in that the needle (9) has two internal channels (14), each channel having an orifice (11).
Citation Information
Patent Citations
Access and vapor containment system for a drug vial and method of making and using same
US20190321262A1
Storage and transfer bottle designed for storing a component of a medicamental substance
US5487737A
Safety drug handling device
US9549875B2
Dual VIAL connecting system for lyophilized products
WO1999009931A1
